These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1141 related articles for article (PubMed ID: 25131982)

  • 1. Triglycerides and cardiovascular disease.
    Nordestgaard BG; Varbo A
    Lancet; 2014 Aug; 384(9943):626-635. PubMed ID: 25131982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
    Nordestgaard BG
    Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.
    Toth PP
    Vasc Health Risk Manag; 2016; 12():171-83. PubMed ID: 27226718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.
    Berglund L; Brunzell JD; Goldberg AC; Goldberg IJ; Stalenhoef A
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):423-37. PubMed ID: 24840268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglycerides and residual risk.
    Vallejo-Vaz AJ; Corral P; Schreier L; Ray KK
    Curr Opin Endocrinol Diabetes Obes; 2020 Apr; 27(2):95-103. PubMed ID: 32073428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remnant cholesterol, vascular risk, and prevention of atherosclerosis.
    Pintó X; Fanlo M; Esteve V; Millán J;
    Clin Investig Arterioscler; 2023; 35(4):206-217. PubMed ID: 36889989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demystifying the management of hypertriglyceridaemia.
    Watts GF; Ooi EM; Chan DC
    Nat Rev Cardiol; 2013 Nov; 10(11):648-61. PubMed ID: 24060958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Residual risk: The roles of triglycerides and high density lipoproteins].
    Grammer T; Kleber M; Silbernagel G; Scharnagl H; März W
    Dtsch Med Wochenschr; 2016 Jun; 141(12):870-7. PubMed ID: 27305303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CE: Triglycerides: Do They Matter?
    Scordo K; Pickett KA
    Am J Nurs; 2017 Jan; 117(1):24-31. PubMed ID: 28030403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased triglycerides and/or low HDL cholesterol. A risk factor needing treatment?].
    Steinmetz A
    MMW Fortschr Med; 2002 Aug; 144(31-32):20-3. PubMed ID: 12422724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of non-fasting and postprandial hypertriglyceridemia and remnant cholesterol.
    Nordestgaard BG; Freiberg JJ
    Curr Vasc Pharmacol; 2011 May; 9(3):281-6. PubMed ID: 21314630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Statin therapy for atherogenic hypertriglyceridemia].
    Koba S
    Nihon Rinsho; 2013 Sep; 71(9):1655-60. PubMed ID: 24205730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertricglyceridemia: prognostic impact and treatment options].
    Custodis F; Laufs U
    Dtsch Med Wochenschr; 2011 Jul; 136(30):1533-42. PubMed ID: 21789752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
    Ito MK
    Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation and management of hypertriglyceridaemia.
    Ferns G; Keti V; Griffin B
    J Clin Pathol; 2008 Nov; 61(11):1174-83. PubMed ID: 18955574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement.
    Kolovou GD; Mikhailidis DP; Kovar J; Lairon D; Nordestgaard BG; Ooi TC; Perez-Martinez P; Bilianou H; Anagnostopoulou K; Panotopoulos G
    Curr Vasc Pharmacol; 2011 May; 9(3):258-70. PubMed ID: 21314632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride Treatment in the Age of Cholesterol Reduction.
    Agrawal N; Freitas Corradi P; Gumaste N; Goldberg IJ
    Prog Cardiovasc Dis; 2016; 59(2):107-118. PubMed ID: 27544319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.